Recombinant Human PLA2G7/Lp-PLA2 Protein (His Tag)
Recombinant Human PLA2G7/Lp-PLA2 Protein (His Tag) supplied by Elabscience with collaborator-provided technical specifications. Read more ›
["Measured by its ability to cleave a colorimetric peptide substrate, 1O-hexadecyl-2-deoxy-2-thio Sacetylsnglyceryl-3-phosphoryl choline (2-Thio-PAF), in the presence of 5, 5’Dithiobis(2-nitrobenzoic acid) (DTNB). The specific activity is > 5000 pmoles/min/μg. ,50-55 kDa"]Product Description
PLA2G7/Lp-PLA2 is the stated recombinant protein target for this Elabscience product. The listing uses collaborator-supplied specifications to support research-use-only protein selection through ABMIUM.
Protein profile: reactive species/source: Human; expression system: HEK293 Cells; physical form: Lyophilized from sterile 50mM NaAc, 150mM NaCl, 10% glycerol, pH 5.0<br/>Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.<br/>Please refer to the specific buffer information in the printed manual.; tag: Human ,PLA2G7/Lp-PLA2 ,Recombinant Proteins; predicted molecular weight: 49.2 kDa.
Quality and formulation: purity: > 88 % as determined by reducing SDS-PAGE.; endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method..
Functional evidence: activity: Measured by its ability to cleave a colorimetric peptide substrate, 1O-hexadecyl-2-deoxy-2-thio Sacetylsnglyceryl-3-phosphoryl choline (2-Thio-PAF), in the presence of 5, 5’Dithiobis(2-nitrobenzoic acid) (DTNB). The specific activity is > 5000 pmoles/min/μg.. In the ABMIUM matrix, collaborator-supplied functional evidence is marked C; unsupported application columns remain N.
Sequence coverage: 49.2 kDa.
Database references: UniProt: Q13093-1 | NCBI Gene: 7941 | Gene symbol: PLA2G7/Lp-PLA2.
Research Use Only.
Key Facts
| Target | PLA2G7/Lp-PLA2 |
| Also known as | 1-alkyl-2-acetylglycerophosphocholine esterase, 2-acetyl-1-alkylglycerophosphocholine esterase, EC 3.1.1, EC 3.1.1.47, Group-VIIA phospholipase A2, LDL-PLA(2), LDL-PLA2, LDL-associated phospholipase A2, Lp, LpPLA2, gVIIA-PLA2, lipoprotein-associated phospholipase A2 |
| Species reactivity | Human |
| Purity | > 88 % as determined by reducing SDS-PAGE. |
| Form / buffer | Lyophilized from sterile 50mM NaAc, 150mM NaCl, 10% glycerol, pH 5.0 Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization. Please refer to the specific buffer information in the printed manual. |
| Shelf life | 12 months |
| Research area | Immunology, Cardiovascular |
| BIOACTIVITY | BINDING | CELL-BASED | IN VIVO | ELISA CAPTURE | |
|---|---|---|---|---|---|
| Human |
Specifications
Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Manufactured under ISO 14001:2015 quality management standards.
Manufactured under ISO 45001:2018 quality management standards.
Not intended for diagnostic or therapeutic use.
Substance does not appear on the SVHC candidate list.